← Back to Search

Behavioural Intervention

E-Cigarette Flavors for Vaping Effects

N/A

Recruiting

Led By Caroline O Cobb, PhD

Research Sponsored by Virginia Commonwealth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 55 minutes (session 1) and up to 120 minutes (sessions 2-4) into the session

Awards & highlights

Study Summary

This trial will test how nicotine levels and flavors in e-cigarettes affect abuse liability indices in current smokers.

Who is the study for?

This trial is for healthy adult smokers who use cigarettes at least three days a week, with at least one cigarette per day. Participants must be willing to give informed consent and attend lab sessions. Pregnant or breastfeeding women cannot join. More eligibility details will be shared after the study ends.Check my eligibility

What is being tested?

The study is examining if different flavors and nicotine levels in e-cigarettes affect how likely people are to keep using them compared to their own brand of cigarettes. It involves comparing tobacco-flavored e-cigarettes with varying nicotine delivery against regular cigarettes and testing menthol flavor's influence.See study design

What are the potential side effects?

Potential side effects may include typical reactions associated with nicotine products such as dizziness, dry mouth, throat irritation, or increased heart rate. Specific side effects related to this trial have not been detailed but can align with common e-cigarette use.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 55 minutes (session 1) and up to 120 minutes (sessions 2-4) into the session

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 55 minutes (session 1) and up to 120 minutes (sessions 2-4) into the session

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 55 minutes (session 1) and up to 120 minutes (sessions 2-4) into the session for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Breakpoint of Drug Purchase Task (DPT)

Cross-price elasticity of the Cross Product-DPT

Elasticity of Drug Purchase Task (DPT)

+3 more

Other outcome measures

Change in Heart Rate

General Labeled Magnitude Scale

Labeled Hedonic Scale

+3 more

Trial Design

7Treatment groups

Experimental Treatment

Active Control

Group I: NJOY Daily 6.0% nicotine ECIG - Menthol flavorExperimental Treatment1 Intervention

Group II: NJOY Daily 6.0% nicotine ECIG - Extra Rich Tobacco flavorExperimental Treatment1 Intervention

Group III: NJOY Ace 5.0% nicotine ECIG - Menthol flavorExperimental Treatment1 Intervention

Group IV: NJOY Ace 5.0% nicotine ECIG - Classic Tobacco flavorExperimental Treatment1 Intervention

Group V: NJOY Ace 2.4% nicotine ECIG - Menthol flavorExperimental Treatment1 Intervention

Group VI: NJOY Ace 2.4% nicotine ECIG - Classic Tobacco flavorExperimental Treatment1 Intervention

Group VII: Own Brand CigaretteActive Control1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor

699 Previous Clinical Trials

22,885,009 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,470 Previous Clinical Trials

2,619,695 Total Patients Enrolled

10 Trials studying Vaping

5,072 Patients Enrolled for Vaping

Caroline O Cobb, PhDPrincipal InvestigatorVirginia Commonwealth University

2 Previous Clinical Trials

242 Total Patients Enrolled

Media Library

Tobacco product administration and assessment (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05971823 — N/A

Vaping Clinical Trial 2023: Tobacco product administration and assessment Highlights & Side Effects. Trial Name: NCT05971823 — N/A

Tobacco product administration and assessment (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05971823 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I qualify to participate in this research endeavor?

"Eligibility for entry into this study is restricted to candidates that have vaped in the past and are aged between 18-55. The trial aims to accrue 36 participants."

Answered by AI

Is geriatric participation acceptable for this clinical experiment?

"This trial is open to participants aged between 18 and 55 years old. Patients younger than 18 or older than 65 can look into 1 or 3 alternative studies, respectively."

Answered by AI

Is the research team currently recruiting participants for this experiment?

"According to records on clinicaltrials.gov, this research project is not currently recruiting participants. The trial was first posted on August 1st 2023 and the most recent edit made was July 31st 2023; however there are 12 additional studies that presently require volunteers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effects of Electronic Cigarette Flavors on Abuse Liability in Smokers (P3-Taste)

2023. "Effects of Electronic Cigarette Flavors on Abuse Liability in Smokers (P3-Taste)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05971823.